ArticleThe American journal of tropical medicine and hygiene2026
A Diagnostic Algorithm Based on Urine Antigen and Blood Polymerase Chain Reaction Testing for Visceral Leishmaniasis in HIV-Coinfected Patients in Northwest Ethiopia.
Article in The American journal of tropical medicine and hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03013673 (Predicting Visceral Leishmaniasis in HIV Infected Patients), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Predicting Visceral Leishmaniasis in HIV Infected Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis of visceral leishmaniasis (VL) in HIV patients relies on tissue aspiration, which is potentially life-threatening. Because antibody-based tests are unreliable for this group, Leishmania blood polymerase chain reaction (PCR) and urine antigen tests can serve as noninvasive alternatives. Using data from the PreLeisH cohort (ClinicalTrials.gov [NCT03013673]), the diagnostic accuracy of these two tests was determined individually, and an algorithm was designed for targeted tissue aspiration. Of the 490 PreLeish participants, 51 underwent diagnostic procedures for VL 118 times at different follow-up time points when clinically suspected. Of these, 48 (94.1%) patients with 102 (84.4%) procedures had complete data, including tissue aspiration, Leishmania kinetoplast DNA blood PCR, and urine antigen (KAtex [Kalon Biological Ltd., Guildford, United Kingdom]) results. The diagnostic performance of KAtex and blood PCR testing was assessed individually against tissue aspiration, and sequential and parallel algorithms were developed. Visceral leishmaniasis was confirmed via tissue microscopy in 55/102 (54%) episodes. The sensitivity and specificity of blood PCR testing were 98% and 64%, respectively; the sensitivity and specificity of KAtex testing were 93% and 81%, respectively. A sequential algorithm using KAtex first and restricting PCR to KAtex-negative suspects limited PCR testing to 42 (41.2%) episodes and tissue aspiration to 14 (13.7%) episodes, with sensitivity, specificity, and positive predictive value of 100%, 81%, and 86%, respectively. The parallel testing algorithm exhibited comparable performance but requires PCR testing for all suspects. The sequential KAtex and PCR testing algorithm, combined with targeted tissue aspiration, met the WHO target product profile, except for specificity. This approach supports efficient resource use and reduces the need for invasive procedures.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.